000 | 07128cam a2200697Mi 4500 | ||
---|---|---|---|
001 | on1103254252 | ||
003 | OCoLC | ||
005 | 20240729132252.0 | ||
006 | m d | ||
007 | cr |n||||||||| | ||
008 | 140307t20152015paua ob 001 0 eng d | ||
010 | _a 2014009474 | ||
040 |
_aVT2 _beng _cVT2 _dOCLCO _dYDXCP _dNLE _dOCLCF _dYDX _dN$T _dIAV _dD6H _dAGLDB _dIGB _dCN8ML _dSNK _dINTCL _dMHW _dBTN _dAUW _dVTS _dAU@ _dUWO _dG3B _dS8I _dS8J _dS9I _dSTF _dSCB _dCOCUF _dUAB _dCEF _dK6U _dUSU _dOCLCO _dOCLCA _dOCLCO |
||
019 |
_a921983596 _a1104427773 _a1104441122 _a1104449479 _a1107546129 _a1109954492 |
||
020 |
_a9781451186857 _q(alk. paper) |
||
020 |
_a1451186851 _q(alk. paper) |
||
020 |
_a9781496324436 _q(electronic bk.) |
||
020 |
_a1496324439 _q(electronic bk.) |
||
020 |
_a9781469883496 _q(electronic bk.) |
||
020 |
_a146988349X _q(electronic bk.) |
||
035 |
_a1484404 _b(N$T) |
||
035 |
_a(OCoLC)1103254252 _z(OCoLC)921983596 _z(OCoLC)1104427773 _z(OCoLC)1104441122 _z(OCoLC)1104449479 _z(OCoLC)1107546129 _z(OCoLC)1109954492 |
||
060 | 1 | 0 | _aQZ 241 |
072 | 7 |
_aHEA _x039000 _2bisacsh |
|
072 | 7 |
_aMED _x014000 _2bisacsh |
|
072 | 7 |
_aMED _x022000 _2bisacsh |
|
072 | 7 |
_aMED _x112000 _2bisacsh |
|
072 | 7 |
_aMED _x045000 _2bisacsh |
|
049 | _aMAIN | ||
130 | 0 | _aNuclear oncology (Aktolun) | |
245 | 1 | 0 |
_aNuclear oncology _c _h[E-Book] |
264 | 1 |
_aPhiladelphia : _bWolters Kluwer, _c[2015] |
|
300 |
_a1 online resource (xxii, 711 pages :) _billustrations (some color) |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_adata file _2rda |
||
380 | _aAktolun | ||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | 0 |
_tBrain tumors / _rZuzan Cayci -- _tHead and neck carcinomas / _rMuhammad Ali Chaudhry, Lujaien Al-Rubaiey Kadhim, and Richard L. Wahl -- _tThyroid carcinoma / _rCumali Aktolun, Umut Elboga and Muammer Urhan -- _tParathyroid tumors / _rChristopher J. Palestro and Kenneth J. Nichols -- _tEsophageal carcinoma / _rMark Dunphy and Heiko Schoder -- _tGastric carcinoma-I / _rKen Herrmann [and others] -- _tGastric carcinoma-II / _rKemal Metin Kir and Elgin Ozkan -- _tPancreatic carcinoma / _rChristina Blumel and Andreas K. Buck -- _tColorectal carcinoma / _rGregory C. Ravizzini, Revathy B. Lyer, and Homer A. Macapinlac -- _tLiver tumors / _rScarlett Lewitschnig [and others] -- _tBreast carcinoma / _rCumali Aktolun, Muammer Urhan, and Umut Elboga -- _tPulmonary carcinoma / _rPietro Muto [and others] -- _tRenal carcinoma / _rAntonija Balenovic, Jasna Mihailovic, and Katherine Zukotynski -- _tProstate carcinoma / _rMarina Hodolic and Stanley J. Goldsmith -- _tUterine and cervical carcinoma / _rBerna Degirmenci Polack -- _tOvarian carcinoma / _rMarie Lacombe [and others] -- _tTesticular germ cell tumors / _rChristoph Oing, Carsten Bokemeyer, and Karin Oechsle -- _tTumors of the adrenal glands / _rShinji Yamamoto, Per Hellman and Anders Sundin -- _tNeuroendocrine tumors / _rLisa Bodei [and others] -- _tLymphoma and leukemia / _rJasna Mihailovic and Stanley J. Goldsmith -- _tMelanoma / _rAlice Lorenzoni [and others] -- _tNeuroblastoma / _rEttore Seregni [and others] -- _tBone tumors / _rJohannes Czernin and Ken Herrmann -- _tPediatric tumors / _rReza Vali and Martin Charron -- _tCancer of unknown primary / _rZohar Keidar, Gad Abikhzer, and Ron Epelbaum -- _tAssessment of lymph nodes in oncology / _rAnsje S. Fortuin [and others] -- _tSentinel lymph node detection and imaging in oncology / _rGang Cheng, Drew A. Torigian and Abass Alavi -- _tPET/CT hybrid imaging in radiotherapy planning / _rEgesta Lopci [and others] -- _tBone mineral densitometry in oncology / _rWilliam D. Leslie -- _tNon-FDG PET/CT imaging in oncology / _rCristina Nanni [and others] -- _tAssessment of response to antitumor treatment / _rMasahiro Yanagawa [and others] -- _tRadionuclide imaging for the assessment of toxicity due to chemotherapy / _rMarcel P.M. Stokkel and Linda de Wit-van der Veen -- _tRadionuclide imaging of multidrug resistance / _rSabina Dizdarevic and A. Michael Peters. -- _tRadionuclide imaging of tumor hypoxia and its clinical implications / _rGang Niu and Xiaoyuan Chen -- _tRadionuclide imaging of tumor cell apoptosis / _rPaola A. Erbe [and others] -- _tRadionuclide imaging of tumor angiogenesis / _rZhao-Hui Jin, Takako Furukawa, and Tsuneo Saga -- _tRadionuclide imaging of tumor cell proliferation / _rSridhar Nimmagadda and Anthony F. Shields -- _tRadionuclide imaging of human epidermal receptors / _rSibaprasad Bhattacharyya [and others] -- _tRadionuclide imaging of integrins / _rMasashi Ueda, Takashi Temma, and Hideo Saji -- _tRadionuclide imaging of annexins / _rChristel Vangestel [and others] -- _tRadiochemistry in nuclear oncology / _rRoland Haubner and Olaf Prante -- _tAdvances in nuclear and optical imaging of tumors : multi-modality, small-animal, and intraoperative technologies / _rPat Zanzonico. |
520 | 8 | _aNuclear Oncology a contemporary narrative of the role of nuclear medicine in oncology with an emphasis on SPECT/CT and PET/CT with additional comments when appropriate on the potential application of PET/MR and to a lesser degree, targeted radionuclide therapy. This book focuses on the use of radionuclides in the diagnosis and treatment of malignant diseases. It describes relevant approved and investigational clinical applications, instrumentation and technology, chemistry and practical clinical issues in nuclear oncology. The basic science and current research topics of nuclear oncology are addressed in separate chapters. Nuclear medicine has become an essential component to all phases of the management of the patient with a malignant tumor and in some cases, even benign neoplasms. The standard of practice for many tumors requires PET/CT imaging at various stages of diagnosis and management. In addition to clinical applications, ongoing investigational efforts, which more and more involve multi-institutional protocols, are also presented.Features:;*;Focuses on the use of radionuclides in the diagnosis and treatment of malignant diseases;*;Emphasizes SPECT/CT and PET/CT with additional emphasis on the potential application of PET/MR;*;Describes relevant approved and investigational clinical applications, instrumentation and technology, chemistry and practical clinical issues in nuclear oncology. | |
590 | _aWorldCat record variable field(s) change: 650 | ||
650 | 0 |
_aCancer _xRadionuclide imaging. |
|
650 | 0 |
_aCancer _xRadiotherapy. |
|
650 | 0 | _aRadioisotope scanning. | |
650 | 1 | 2 |
_aRadionuclide Imaging _97670 |
650 | 1 | 2 |
_aNeoplasms _xdiagnostic imaging |
650 | 2 | 2 |
_aNeoplasms _xradiotherapy |
650 | 2 | 2 |
_aRadionuclide Imaging _xmethods |
650 | 2 | 2 |
_aRadiotherapy _xmethods |
650 | 2 | _aRadiation Oncology | |
700 | 1 |
_aAktolun, C. _q(Cumali), _d1961- _eeditor. |
|
700 | 1 |
_aGoldsmith, Stanley J., _eeditor. |
|
856 |
_u#gotoholdings _yAccess resource |
||
887 | _aRC270.3.R35N83 2015 | ||
938 |
_aEBSCOhost _bEBSC _n1484404 |
||
938 |
_aYBP Library Services _bYANK _n12399327 |
||
938 |
_aYBP Library Services _bYANK _n13669001 |
||
942 | _n0 | ||
994 |
_a92 _bN$T |
||
999 |
_c92753 _d92753 |